Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘(NASDAQ:ARQL)’

Samuel Isaly Orbimed Advisors

Hedge Funds Are Starting To Cash Out Of ArQule, Inc. (ARQL)

We can judge whether ArQule, Inc. (NASDAQ:ARQL) is a good investment right now by following the lead of some of the best investors in the world and piggybacking......(read more)
Oleg Nodelman EcoR1 Capital

Hedge Funds Have Never Been This Bullish On ArQule, Inc. (ARQL)

Is ArQule, Inc. (NASDAQ:ARQL) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on......(read more)
Countries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: Simon Sadler, Ray Dalio, George Soros, Neil Woodford, Warlander Asset Management, ArQule, Inc. (ARQL), Century Communities Inc (CCS), and More

New Blackpool Owner Simon Sadler: ‘I’m Doing it for the Greater Good’ (The Guardian) If Blackpool supporters who fought the arduous campaign against......(read more)

Did Hedge Funds Drop The Ball On ArQule, Inc. (ARQL) ?

“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively......(read more)
MILLENNIUM MANAGEMENT

ArQule, Inc. (ARQL): Are Hedge Funds Right About This Stock?

Before we spend days researching a stock idea we’d like to take a look at how hedge funds and billionaire investors recently traded that stock.......(read more)
biotechnological

13G Filing: Biotechnology Value Fund LP and Arqule Inc (ARQL)

Arqule Inc (NASDAQ:ARQL): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP’s......(read more)
Easiest Md/PhD Programs to Get Into

13G Filing: Biotechnology Value Fund L P and Arqule Inc (ARQL)

Arqule Inc (NASDAQ:ARQL): Mark Lampert’s Biotechnology Value Fund LP filed an amended 13D. You can check out Biotechnology Value Fund LP’......(read more)
drug factory, researcher,

ArQule, Inc. (ARQL)’s Liver Cancer Drug Fails: What’s Next?

ArQule, Inc. (NASDAQ:ARQL) took a real hit at the end of last week, as the company announced data from a late stage oncology trial. The data did not read......(read more)
test, cancer, researcher, research, dna, bio, clean, modern, chemistry, human, white, medical, sample, pipette, life, culture, laboratory, biotechnology, genetic, disease,

How ArQule, Inc. (ARQL) Stacks Up Against Its Peers

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Here’s What The ArQule, Inc. (ARQL) Data Really Means

We just got some interim data from ArQule, Inc. (NASDAQ:ARQL), and there looks to be a bit of confusion as to what the data actually says about drug in......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Pfizer Inc (PFE) Reports 4.4% Position in Arqule Inc (ARQL)

Pfizer Inc. (NYSE:PFE) has reported holding a 4.4% position in microcap biopharmaceutical company ArQule, Inc. (NASDAQ:ARQL). As a filing with the US......(read more)
, group, growth, dream, dollar, earnings, photography, closeup, advertisement, heap, debt, nobody, rate, increment, income, yellow, stack, multiplication, finance

13G Filing: Nantahala Capital Management and Arqule Inc (ARQL)

A recent filing with the US Securities and Exchange Commission showed that Wilmot B. Harkey and Daniel Mack‘s Nantahala Capital Management holds......(read more)
BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)

Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) a good investment? At the moment, there are many indicators market participants can use to......(read more)

This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)

Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment......(read more)
CONN'S, Inc. (NASDAQ:CONN)

CONN’S, Inc. (CONN), ArQule, Inc. (ARQL), VIVUS, Inc. (VVUS): Last Week’s Biggest Losers

There’s never a shortage of losers in the stock market. Let’s take a closer look at five of this past week’s biggest sinkers. Company......(read more)
Pain Therapeutics, Inc. (NASDAQ:PTIE)

Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?

Should Pain Therapeutics, Inc. (NASDAQ:PTIE) investors track the following data? In the eyes of many investors, hedge funds are viewed as overrated,......(read more)
ArQule, Inc. (NASDAQ:ARQL)

What Hedge Funds Think About ArQule, Inc. (ARQL)

Is ArQule, Inc. (NASDAQ:ARQL) a good investment? In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks......(read more)
Cytokinetics, Inc. (NASDAQ:CYTK)

What’s a Smart Cytokinetics, Inc. (CYTK) Investor To Do?

What’s a smart Cytokinetics, Inc. (NASDAQ:CYTK) investor to do? In the eyes of many of your peers, hedge funds are seen as useless, old investment......(read more)

Hedge Funds Are Buying ZIOPHARM Oncology Inc. (ZIOP)

Is ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) a buy, sell, or hold? The best stock pickers are taking a bullish view. The number of bullish hedge fund bets......(read more)
Cytokinetics, Inc. (NASDAQ:CYTK)

Cytokinetics, Inc. (CYTK): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds’ portfolio at the end of March. CYTK shareholders have witnessed an increase in support from......(read more)

Hedge Funds Are Crazy About Cytokinetics, Inc. (CYTK)

Is Cytokinetics, Inc. (NASDAQ:CYTK) the right pick for your portfolio? Prominent investors are in a bullish mood. The number of bullish hedge fund bets......(read more)

Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds’ portfolio at the end of March. FOLD shareholders have witnessed an increase in enthusiasm......(read more)
BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

Is BioDelivery Sciences International, Inc. (BDSI) Going to Burn These Hedge Funds?

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders have witnessed a decrease in hedge fund sentiment of late; stagnant interest is a......(read more)
ArQule, Inc. (NASDAQ:ARQL)

ArQule, Inc. (ARQL): Hedge Funds and Insiders Are Bearish, What Should You Do?

Is ArQule, Inc. (NASDAQ:ARQL) a buy here? The best stock pickers are reducing their bets on the stock. The number of bullish hedge fund bets were cut......(read more)

Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?

Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood. The number of long hedge fund positions were trimmed......(read more)

Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?

Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident. The number of bullish hedge fund......(read more)
ArQule, Inc. (NASDAQ:ARQL)

Is ArQule, Inc. (ARQL) Going to Burn These Hedge Funds?: ShangPharma Corp (ADR) (SHP), OncoGenex Pharmaceuticals Inc (OGXI)

ArQule, Inc. (NASDAQ:ARQL) was in 13 hedge funds’ portfolio at the end of December. ARQL investors should pay attention to a decrease in hedge fund......(read more)